Shelley T Bell, in Kingsport, TN - Speech-Language Pathologist

Shelley T Bell, is a Speech-language Pathologist based in Kingsport, Tennessee. Shelley T Bell is licensed to practice in Tennessee (license number 4014) and her current practice location is 2005 Venture Park, Suite 17, Kingsport, Tennessee. She can be reached at her office (for appointments etc.) via phone at (423) 207-1260.

NPI number for Shelley T Bell is 1396986964 and her current mailing address is 716 W Hillcrest Dr, Johnson City, Tennessee. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1396986964.

Contact Information

	Shelley T Bell,
	2005 Venture Park, Suite 17, Kingsport, TN 37660-1098
	(423) 207-1260
	Not Available

Healthcare Provider's Profile

Full Name	Shelley T Bell
Gender	Female
Speciality	Speech-language Pathologist
Location	2005 Venture Park, Kingsport, Tennessee
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1396986964
Provider Enumeration Date: 03/11/2009
Last Update Date: 03/11/2009

Medical Identifiers

Medical identifiers for Shelley T Bell such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1396986964	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
235Z00000X	Speech-language Pathologist	4014 (Tennessee)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Shelley T Bell is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Shelley T Bell, 716 W Hillcrest Dr, Johnson City, TN 37604-4416 Ph: (423) 737-1527	Shelley T Bell, 2005 Venture Park, Suite 17, Kingsport, TN 37660-1098 Ph: (423) 207-1260

News Archive

Induction chemotherapy fails to improve survival in head and neck cancer patients

Head and neck cancer patients who receive chemotherapy prior to radiation therapy (induction chemotherapy or IC) rather than the standard treatment that combines chemotherapy with radiation (chemoradiation or CRT) show no survival benefit and are less likely to receive a full course of radiation, according to research from the University of Colorado Cancer Center presented at the 2016 Multidisciplinary Head and Neck Cancer Symposium.

Researchers develop C5 technology to identify CTCs in breast cancer

Researchers have identified a novel, dual-platform technology, the On-Q-ity Circulating Cancer Capture and Characterization Chip (C5), which they believe is more efficient than the commonly used single-platform device in identifying circulating tumor cells (CTCs) in breast cancer.

Results reported for clinical trial for the treatment of depression using external trigeminal nerve stimulation

Earlier today, at the American Psychiatric Association Annual Meeting in Philadelphia, Dr. Ian Cook, Principal Investigator and Professor of Psychiatry at UCLA, and a Senior Medical Advisor to NeuroSigma, Inc., presented the results of a Phase Ib open-label clinical trial that studied the effects of eTNS™ on depressive symptoms in Major Depressive Disorder (MDD) as an adjunct to pharmacotherapy. Results from the 17-question Hamilton Depression Rating Scale (HDRS-17), a clinician-rated scale, showed a 50.0% reduction in depression and the Beck Depression Inventory (BDI), a self-reported scale, showed a 58.0% reduction in scores. Both scales achieved statistical significance. In the trial, subjects placed stimulating eTNS™ electrodes on their foreheads for 8 hours each night and their depression was measured every two weeks using recognized standard tests. eTNS was well tolerated and no serious adverse events occurred during the 8-week treatment period.

Use of liver grafts from older donors decreased despite better outcomes in recipients

More than 10 percent of patients waiting for a liver transplant die each year. This observational study looked at trends in the transplantation of livers from older donors and outcomes in recipients of these older livers from 2003 to 2016.

Targeting a single protein can help fight both breast cancers and leukemias

Targeting a single protein can help fight both breast cancers and leukemias, according to two reports published online on January 23 in the Journal of Experimental Medicine.

Speech-Language Pathologist in Kingsport, TN

Sarah Taylor, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 301 Louis St, Suite 191, Kingsport, TN 37660 Phone: 423-246-4600 Fax: 423-246-3311
Mrs. Rebekah Watson, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 301 Louis St, Kingsport, TN 37660 Phone: 423-534-5441
Caroline Mcfee, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 301 Louis St Ste 101, Kingsport, TN 37660 Phone: 423-246-4600
Haven Crawley Brooks, M.S., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 301 Louis St Ste 101, Kingsport, TN 37660 Phone: 423-246-4600
Hannah Paige Collie, SLP-CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 301 Louis St Ste 101, Kingsport, TN 37660 Phone: 423-246-4600
Rachel E Trent, M.S. CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 301 Louis St Ste 101, Kingsport, TN 37660 Phone: 423-246-4600 Fax: 423-246-3311
Lindsy Philllips, Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2421 N John B Dennis Hwy, Kingsport, TN 37660 Phone: 423-288-3988

Shelley T Bell, - Speech-Language Pathologist in Kingsport, TN